Pre-Open Stock Movers 04/12: (FOLD) (ARNA) (HLX) Higher; (HZNP) (OZM) (JNPR) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- Forward Air (FWRD) Appoints Shawn Stewart as CEO
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
Brean Capital Cuts Price Target After Horizon Pharma (HZNP) Releases Soft Guidance
April 14, 2016 9:40 AM EDTBrean Capital maintained a Buy rating on Horizon Pharma (NASDAQ: HZNP), and cut the price target to $30.00 (from $32.00), after the company provided soft 1Q and 2Q guidance. The company now expects to generate 19-20%/22-23%/57-59% of FY16 sales vs. previous consensus estimates of... More
UBS Cuts Price Target on Horizon Pharma (HZNP) After Meeting with Management
April 13, 2016 8:20 AM EDTUBS maintained a Buy rating on Horizon Pharma (NASDAQ: HZNP), and cut the price target to $24.00 (from $39.00), after meeting with management. Horizon is expecting the 1H16 to be slower than 2H16 as it needs to absorb the deductibles that patients cover before drug... More
Piper Jaffray Remains Bullish on Horizon Pharma (HZNP) as Stock Loses Value
April 13, 2016 7:55 AM EDTPiper Jaffray maintained an Overweight rating and $44.00 price target on Horizon Pharma (NASDAQ: HZNP) after the stock loses over a quarter of its value following detail from management regarding the cadence of expected quarterly results. Management cited a higher than expected gross-to-net spreads as one driver associated with lower 1Q16 EPS contribution versus other... More
Stifel Remains Bullish on Juniper Networks (JNPR) Despite Soft March Pre-Announcement
April 12, 2016 10:22 AM EDTStifel maintained a Buy rating on Juniper Networks (NYSE: JNPR), and cut the price target to $28.00 (from $34.00), following the company's pre-announced march quarter results. Revenues and EPS are expected to come in below the companys, already below consensus, guidance. Stifel... More
